@article{Kamyshna_2022, title={The role of vitamin D for the management of depression in patients with autoimmune thyroiditis and hypothyroidism in the West-Ukrainian population}, volume={18}, url={https://iej.zaslavsky.com.ua/index.php/journal/article/view/1173}, DOI={10.22141/2224-0721.18.4.2022.1173}, abstractNote={<p><strong>Background.</strong> Hashimoto’s thyroiditis is known to be an essential endocrine disease that affects the population and may lead to hypothyroidism. This disease is one of the most commonly spread autoimmune di­seases. Hypothyroid patients frequently experience features of depression, which is prevalent among other symptoms in hypothyroidism. Data from recent research has proved that vitamin D deficiency may cause depression manifestations in the population. The purpose of the work is to study the effect of cholecalciferol in patients with autoimmune thyroiditis and hypothyroidism in the West-Ukrainian population on the level of depression in these patients. <strong>Materials and methods.</strong> The study included the 56 patients with hypothyroidism (H) caused by autoimmune thyroiditis (AIT). We identified the severity of depression levels using the Hamilton Depression Rating Scale (HDRS), which is reliable for depression assessment. Examinations were performed at the beginning and end of the 12-week treatment. <strong>Results.</strong> In patients of group 1 who received cholecalciferol and L-thyroxine, the level of depression on the Hamilton scale decreased by 40 %, while in patients who received only L-thyroxine, the level of depression decreased by 25 %. In addition, there was a significant difference between patients in groups 1 and 2 after treatment (p = 0.003). That is, treatment with additional cholecalciferol on the background of L-thyroxine was more effective than treatment with L-thyroxine alone. Analyzing the effect of treatment in patients with Group 1 with the additional appointment of cholecalciferol on the background of L-thyroxine in 21.4 % of patients disappeared depression. In addition, there was a decrease in depression in other patients in this group. Thus, in the remaining patients the severity of depressive manifestations decreased from moderate severity to mild depressive disorder. At the same time, after treatment only L-thyroxine depressive disorder of moderate severity decreased from 78.6 to 35.7 % to mild depressive disorder, but complete disappearance of depression in this group of patients after treatment was not observed. <strong>Conclusions.</strong> Vitamin D supplementation should be administered in patients suffering from autoimmune thyroiditis and hypothyroidism which may correct depression disorders in these patients.</p>}, number={4}, journal={INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)}, author={Kamyshna, Iryna}, year={2022}, month={Jun.}, pages={208–212} }